Morrisville, NC, United States of America

Edward Browka

This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignee: Tearclear Corp.. Active years: 2023-2024.


% Patents Active = 100.0

 

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Edward Browka: Innovator in Ophthalmic Flow Control Technologies

Introduction

Edward Browka is a notable inventor based in Morrisville, NC (US). He has made significant contributions to the field of ophthalmic formulations, particularly in the area of flow control devices. With a total of 2 patents to his name, Browka's work is recognized for its innovative approach to improving the delivery of ophthalmic agents.

Latest Patents

Browka's latest patents focus on devices and methods for flow control of ophthalmic formulations. One of his inventions is a flow control device designed for a compressible bottle. This device includes a reservoir that contains an ophthalmic formulation, which consists of an ophthalmic agent and a preservative. The reservoir features a reservoir interface at its mouth, which contains one or more apertures that connect the interior and exterior of the reservoir. Additionally, the device includes a nozzle with an outlet and a nozzle cap, which also has apertures that connect the outlet to a reservoir-facing surface. The design allows for the rotation of the nozzle about an axis, aligning the apertures in both the reservoir interface and the nozzle cap for optimal flow control.

Career Highlights

Browka is currently associated with Tearclear Corporation, where he continues to develop innovative solutions in the ophthalmic field. His work has been instrumental in advancing technologies that enhance the usability and effectiveness of ophthalmic products.

Collaborations

Some of Browka's notable coworkers include Howard L Golub and Srini Venkatesh. Their collaborative efforts contribute to the innovative environment at Tearclear Corporation.

Conclusion

Edward Browka's contributions to ophthalmic flow control technologies demonstrate his commitment to innovation in the field. His patents reflect a deep understanding of the challenges in delivering ophthalmic formulations effectively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…